Publications

2001

1. Dureja Harish, Tiwary A. K. and Gupta Sunil, Simulation of Skin Permeability in Chitosan Membranes, International Journal of Pharmaceutics, 213, 193-98, 2001. (IF= 3.458) (ISSN: 0378-5173)

2002

2.  Chawla Viney and Dureja Harish, Chitosan - Preparation and Properties, Indian Drugs, 39 (4), 191-94, 2002. (ISSN: 0019-462X)

3. Dureja Harish, Sharma Rishi, Rathore Arvind and Lamba H.S., Permeability Evaluation of Transdermal Drug Delivery Systems,  Journal of Science & Pharmacy, 3(4), 131-38, 2002. (ISSN: 0972-3897)

4. Saggu Jitender Singh, Sharma Rishi, Dureja Harish and Kumar Vipin, Benzimidazoles with Biphenyls: Synthesis of 5-substituted-2-n-propyl-1-[(2’-carboxybiphenyl-4-yl-)methyl] benzimidazoles, Journal of Indian Institute of Science, 82, 177-182, 2002. (ISSN: 0019-4964)

2003

5. Singh Bijender, Dureja Harish, Sharma Rishi, Patil B.M., Effect of Vitamin E on the Impaired Gastrointestinal Activity of Streptozotocin-Induced Diabetic Rats, Indian Journal of Pharmacology, 35, 186-187, 2003. (IF= 0.583) ((ISSN:0253-7613)

6. Harish, Kaushik Deepak, Kumar Vipin and Sardana Satish, Regulatory Aspects of Dietary Supplements, Journal of Science & Pharmacy, 4(3), 89-96, 2003. (ISSN: 0972-3897)

7. Dureja Harish, Kaushik Deepak and Kumar Vipin, Developments in Nutraceuticals, Indian Journal of Pharmacology, 35, 363-372, 2003. (IF= 0.583) (ISSN: 0253-7613)

2004

8. Dureja Harish and Kaushik Deepak, Bar Code in Pharmaceutical Industry, Chronicle Pharmabiz, 4, 8, 2004.

9. Kaushik Deepak, Saini, T. R. and Dureja Harish, Development of Olanzapine Melt-in-Mouth Tablets by Sublimation Technique, Journal of Pharmaceutical Research, 3(2), 35-37, 2004. (ISSN: 0973-7200

10. Kaushik Deepak, Dureja Harish and Saini, T. R., Orally Disintegrating Tablets, Tablets & Capsules, 2, 30-36, 2004. (ISSN: 1549-9928)

11. Dureja Harish and Gupta Sunil, In vitro Permeation of Ionized and Unionized Diclofenac: Comparison of Chitosan Membranes with Rat Skin, Indian Journal of  Pharmaceutical Sciences, 66(1), 108-111, 2004. (IF=0.338) (ISSN: 0250-474X)

12. Saini T. R., Kaushik Deepak and Dureja Harish, Formulation of Lamotrigine Oro-dispersible Tablets by Superdisintegrating Agents, The Indian Pharmacist,3(19), 72-75, 2004. (ISSN: 0972-7914)

13. Kaushik Deepak, Dureja Harish and Saini T. R., Formulation and Evaluation of Olanzapine Mouth Dissolving Tablets by Effervescent Formulation Approach, Indian Drugs, 41(7), 410-412, 2004. (ISSN:0019-462X)

14. Kaushik Deepak, Dureja Harish and Saini T. R., Mouth Dissolving Tablets:  A Review, Indian Drugs, 41,187-193, 2004. (ISSN:0019-462X)

15. Dureja Harish, Kaushik Deepak, Chawla Viney and Sardana Satish, Emerging uses of Chitosan- A Review, Journal of Science & Pharmacy, 5(2), 54-61, 2004.(ISSN: 0972-3897)

16. Ishita, Deepak Kaushik and Harish Dureja, Role of Community Pharmacist in Ensuring Better Healthcare-I, Chronicle Pharmabiz, 4(29), 8, 2004.

17. Ishita, Deepak Kaushik and Harish Dureja, Role of Community Pharmacist in Ensuring Better Healthcare-II, Chronicle Pharmabiz, 4(30), 8, 2004.

18. Kaushik Deepak and Dureja Harish, Patents in Pharmaceuticals: An Indian Scenario, M.D.U. Law Journal, 9, 281-286, 2004.

2005

19. Gupta Meenal, Dureja Harish, Kaushik Deepak and Gupta Sunil, Multivariate Optimization Tools in Pharmaceutical Process and Formulation Development, Drug Delivery Technology, 5(5), 53-61, 2005. (ISSN:1537-2898)

20. Dureja Harish and Madan A. K., Topochemical Models For Prediction of Cyclin-Dependent Kinase 2 Inhibitory Activity of Indole-2-Ones, Journal of Molecular Modeling, 11, 525-531, 2005.

             (IF= 1.984) (ISSN:1610-2940)

21. Virmani Deepti, Gupta Meenal, Kaushik Deepak and Dureja Harish, Bar Code: An Overview, Pharmaceutical Reviews, 3 (1), 2005. (ISSN: 1918-5561)

22. Pandita Deepti, Dureja Harish, Kumar Vipin and Lather Viney, An Introduction to Combinatorial Chemistry: A Rapid Approach to Lead Development, Pharmaceutical Reviews, 3 (2), http://www.pharmainfo.net, 2005. (ISSN: 1918-5561)

23. Sharma Rishi, Dureja Harish, Sharma Ajay and Singh M., Possible Involvement of Stretch-Activated Channels in the Cardioprotective Effect of Remote Aortic Preconditioning, Indian Journal of Pharmaceutical Sciences, 67, 169-174, 2005. (IF= 0.338) ((ISSN: 0250-474X)

24. Dhall Manish, Rao Rekha., Kaushik Deepak, Dureja Harish and Nanda Arun, Ethosomes: A Novel Approach for Enhanced Transdermal Drug Delivery, Indian Drugs, 42(1), 1-7, 2005 ((ISSN:0019-462X)

25. Dureja Harish, Kaushik Deepak, Gupta Meenal, Kumar Vipin and Lather Vinay, Cosmeceuticals: An Emerging concept, Indian Journal of Pharmacology, 37(3), 155-159, 2005. (IF= 0.583) (ISSN: 0253-7613)

26. Dureja Harish, Kaushik Deepak, Kumar Neeraj and Sardana Satish, Aloe Vera, The Indian Pharmacist, 38(IV), 9-13, 2005. (ISSN: 0972-7914)

2006

27. Dureja Harish and Madan A. K., Models for the Prediction of h5-HT2AReceptor Antagonistic Activity of Arylindoles: Computational Approach using Topochemical Descriptors, Journal of Molecular Graphics and Modeling, 25, 373-379, 2006. (IF= 2.325) (ISSN: 1093-3263)

28. Dureja Harish and Madan A. K., Topochemical Models for the Prediction of Permeability through Blood-Brain Barrier,  International Journal of Pharmaceutics, 323, 27-33, 2006. (IF= 3.458) ((ISSN: 0378-5173)

29. Kharb Vivek, Bhatia Meenakshi, Dureja Harish and Kaushik Deepak, Nanoparticle Technology for the Delivery of Poorly Water-Soluble Drugs,  Pharmaceutical  Technology,  30, 82-92, 2006. (ISSN: 1543-2521)

30. Gilhotra Ritu, Gilhotra Neeraj, Kaushik Deepak, Gupta Meenal and Dureja Harish, Alternative Insulin Delivery Systems, Pharmaceutical Reviews, 4 (5), http://www.pharmainfo.net, 2006. (ISSN:1918-5561)

31. Kaushik Deepak, Madan Kumud and Dureja Harish, Near Infra-Red Spectroscopy, Tablets & Capsules, 4, 22-28, 2006. (ISSN: 1549-9928).

2007

32. Dureja Harish, Kumar Vipin, Gupta Sunil and Madan A. K., Topochemical Models for the Prediction of Lipophilicity of 1,3-Disubstituted Propan-2-One Analogues, Journal of Theoretical and Computational Chemistry, 6, 435-448, 2007. (IF=0.633) (ISSN:0219-6336)

33. Dureja Harish and Madan A. K., Topochemical Models for Prediction of Telomerase Inhibitory Activity of Flavonoids, Chemical Biology and  Drug Design, 70, 47-52, 2007. (IF=2.469) (ISSN:1747-0285)

34. Deepti, Dureja Harish and Madan A. K. Solid Dispersion Adsorbates for Enhancement of Dissolution Rate of Drugs, PDA Journal of Pharmaceutical  Science and Technology, 61, 97-101, 2007. (IF=0.393) (ISSN:1079-7440)

35. Dureja Harish and Madan A. K., Topochemical Models for the Prediction of Poly(ADP-Ribose) Polymerase Inhibitory Activity of Indole-1-ones, Medicinal Chemistry Research, 16, 15-27, 2007. (1.612) (ISSN: 1054-2523)

36. Dureja Harish and Madan A. K., Validation of Topochemical Models for the Prediction of Permeability through Blood Brain Barrier, Acta Pharmaceutica, 57, 451-467, 2007. (IF= 1.162) (ISSN:1330-0075)

37. Dureja Harish and Madan A. K., Superaugmented Eccentric Connectivity Indices: New Generation of Highly Discriminating Topological Descriptors for QSAR/QSPR Modeling, Medicinal Chemistry Research, 16, 331-341, 2007. (IF=1.612) (ISSN: 1054-2523)

38. Dureja Harish and Madan A. K., Adsorption in Pharmacy: A Review, Drug Delivery Technology, 7, 58-63, 2007. (ISSN:1573-2898)

39. Singh S.K., Dureja Harish, Mishra D.N. and Pandit J.K., Formulation and Evaluation of Controlled Release Matrix Tablets, Tablets & Capsules, 5, 42-55, 2007. (ISSN:1549-9928)

2008

40. Dureja Harish, Gupta Sunil and Madan A. K., Predicting Anti-HIV-1 Activity of 6-arylbenzonitriles: Computational Approach Using Superaugmented Eccentric Connectivity Topochemical Indices, Journal of  Molecular Graphics and Modeling,26, 1020-1029, 2008. (IF= 2.325) (ISSN:1093-3263)

41. Monika, Dureja Harish and Madan A.K., Development of Sustained Release Solid Dispersion using Factorial Design, Drug Delivery Technology, 5, 47-52, 2008.(ISSN:1537-2898)

42. Dureja Harish, Gupta Sunil and Madan A. K.,Topological Models for Prediction of Pharmacokinetic parameters of cephalosporins using Random Forest, Decision Tree and Moving Average Analysis, Scientia Pharmaceutica, 76, 377-394, 2008.(ISSN:0036-8709)

43. Dureja Harish and Madan A. K., Prediction of Antitumor Activity of N-(Phenylsulfonyl)Benzamides: Computational Approach using Topochemical Descriptors, Leonardo Journal of Sciences, 12, 214-231, 2008. (ISSN:1583-0233)

2009

44. Dureja Harish and Madan A. K., Predicting Anti-HIV Activity of Dimethylaminopyridin-2-Ones: Computational Approach using Topochemical Descriptors, Chemical Biology and Drug Design, 73, 258-270, 2009. (IF= 2.469) (ISSN:1747-0285)

45. Dureja Harish and Madan A. K., Topochemical Model for the Prediction of 5-HT6Binding Affinity of 3-Ethyl-1H-Indoles, Leonardo Journal of Sciences 14, 112-123, 2009 (ISSN:1583-0233)

46. Dureja Harish, Das KC and Madan A. K.,Superpendentic Connectivity Indices: Pendenticity-cum-Adjacency based Topological Descriptors for QSAR/QSPR, Scientia Pharmaceutica, 77, 521-537, 2009. ((ISSN:2218-0532)

47. Datt Rohit, Dureja Harish, and Madan A. K., Models for prediction of anti- HIV-1 activity of 5-Alkyl-2-alkylamino-6-(2,6- difluorophenylalkyl)-3,4-dihydropyrimidin-4(3H)-ones using random forest, decision tree and moving average analysis, Journal of Computational Methods in Sciences and Engineering, 9, 95-112, 2009. (ISSN:1472-7978)

48. Dureja Harish, Gupta Sunil and Madan A. K.,Topological Models for Prediction of Physico-chemical, Pharmacokinetic and Toxicological Properties of Antihistaminic Drugs using Decision Tree and Moving Average Analysis,  International Journal of  Computational  Biology and Drug Design, 2, 353–370, 2009. (ISSN:1756-0756)

49. Swami Ruchika, Kaushik Deepak, Saggu Jitender and Dureja Harish, Medical Devices: A Regulatory overview, Pharmaceutical Reviews, 7(1),  http://www.pharmainfo.net, 2009. (ISSN:1918-5561)

50. Sangwan Sandeep and Dureja Harish, Pharmacosomes: A Potential Alternative To Conventional Vesicular Systems, Pharmaceutical Technology, 33, 62-65, 2009. (ISSN:1543-2521)

51. Ahmad Farhan Jalees, Drabu Sushma, Dureja Harish, Khatri Smriti, Floating Drug Delivery Systems, Asian Journal of Chemistry, 21, 4603-4611, 2009. (IF= 0.247) (ISSN:0970-7077)

2010

52. Goyal R.K., Dureja H., Singh G., Madan A. K., Topological models for the prediction of A3  adenosine receptor binding affinity of 2-Chloro-N6-substituted-4´-thioadenosine-5´-uronamides, International Journal of Chemical  Modeling, 2(4),397-416, 2010. (ISSN:1941-3955)

53. Datt Rohit, Dureja Harish, and Madan A. K., Decision tree and moving average analysis based models for prediction of BRAF inhibitory activity of 2, 6-disubstituted pyrazines, International Journal of Chemical  Modeling, 3(1-2), 73-97, 2010. (ISSN:1941-3955)

54. Rakesh Pahwa, Preeti Bohra, Prabodh Chander Sharma, Vipin Kumar And Harish Dureja, Glipizide : Some analytical, clinical and therapeutic vistas, International Journal of Chemical Sciences, 8(1), 59-80, 2010. (ISSN:0972-768X)

55. Sharma Deepa, Srinivas K. S., Dwivedi D.P., Gupta Pallavi, Dureja Harish, Nagpal Manju, Rakha Pankaj, Goyal Surinder,   Simultaneous estimation of risperidone, olanzapine and quetiapine and its degradation products by HPLC,. Acta Pharmaceutica Scienica, 52, 345-352, 2010 (ISSN:1307-2080)

56. Goyal R., Dureja Harish, Singh G., and Madan A. K., Models for antitubercular activity of 5'-O-[(N-Acyl)sulfamoyl]adenosines, Scientia Pharmaceutica,78, 791–820, 2010. (ISSN:2218-0532)

57. Vipin Sharma, Rakesh Kumar Marwaha, Harish Dureja, Permeability Evaluation Through Chitosan Membranes Using Taguchi Design, Scientia Pharmaceutica,78, 977-983, 2010. (ISSN:2218-0532)

58. Dulichand and Harish Dureja, New Drug Approval Process: Regulatory View, Pharmaceutical Reviews, 8 (4), 2010. (ISSN:1918-5561)

59. Sharma Navneet, Kaushik Deepak and Dureja Harish, Medicated Chewing Gums: A Potential Drug Delivery System, Pharma Buzz, 5(10) 42-48, 2010. 

60. V. S. Rajpurohit, Pankaj Rakha, Surinder Goyal, Harish Dureja, Gitika Arora and Manju Nagpal. Formulation and Characterization of Solid Dispersions of Glimepiride through Factorial Design,  Iranian Journal of Pharmaceutical Sciences, Winter, 7(1): 7-16, 2010. (ISSN:1735-2444)

2011

61. Monika Gupta, Harish Dureja and Anil Kumar Madan, Models for the prediction of receptor tyrosine kinase inhibitory activity of substituted 3-aminoindazole analogues, Scientia Pharmaceutica, 79: 239–257, 2011. (ISSN:2218-0532)

62. Manjeet Kumar and Harish Dureja, Development and Characterization of Factorially Designed 5-Fluorouracil Microspheres. Bulletin of Pharmaceutical Research 1(1), 54-61, 2011. (ISSN: 2249-6041).

63. Swami Ruchika, Singh Govind, Bhasin Parminder and Dureja Harish. In Vitro Dissolution Profile Comparison: Prognostic tool for biowaivers based on BCS, Journal of Pharmaceutical Research, 10 (2), 73-76, 2011. (ISSN:0973-7200)

64. Kamboj M., Goyal S., Rakha P., Arora G., Dureja Harish and Nagapl M., Formulation and Evaluation of Metformin Orodispersidle Tablets, Acta Pol. Pharm. Drug Res., 68(5): 717-723, 2011. (IF=0.660) (ISSN:0001-6873)

65. H. Dureja, S. Khatak, M. Khatak, M. Kalra, Amylose Rich Starch as an Aqueous Based Pharmaceutical Coating Material – Review,  International Journal of Pharmaceutical Sciences and Drug Research, 3(1): 08-12, 2011.(ISSN:0975-248X)

66. Rajashri Ojha, Shivanand Puthli, Dulichand Rohilla and Harish Dureja, Clinical Trials in India: Current Regulatory and Ethical Overview, Entire Research, 3(II): 83-86, 2011. (ISSN:0975-5020)

2012

67. Rakesh K. Goyal, Harish Dureja, G. Singh, A. K. Madan, Models for anti-inflammatory activity of 8-substituted-4-anilino-6-aminoquinoline-3-carbonitriles, Medicinal Chemistry Research, 12: 1044-1055, 2012. (IF=1.612) (ISSN:1054-2523)

68. Monika Gupta, Sunil Gupta, Harish Dureja and Anil Kumar Madan, Superaugmented eccentric distance sum connectivity indices: novel highly discriminating topological descriptors for QSAR/QSPR, Chemical Biology and Drug Design, 79(1): 38-52, 2012. (IF= 2.469) (ISSN: 1747-0285)

69. Nagpal Manju, Maheshwari DK, Rakha P, Dureja Harish, Goyal Surinder, Dhingra G, Formulation Development and Evaluation of Alginate Microspheres of Ibuprofen,.Journal of Young Pharmacists,   4(1): 13-16, 2012. (ISSN: 0975-1483)

70. Vandana Prajapati and Harish Dureja, Product Lifecycle Management In Pharmaceuticals, Journal of Medical Marketing, 12 (3): 150-158, 2012. (ISSN:1745-7904)

71. Neeta, Dureja Harish, Bhagwan Shiv, Seema, Dahiya Jyoti, Fast Dissolving Tablets: an overview, Novel Science International Journal of Pharmaceutical Science, 1(5): 228-232, 2012. (ISSN:2278-0033)

72. Kumar Anuj, Dureja Harish, Madan Anil K, Selection of Color Additives: A Regulatory View, International Journal of Pharmaceutical Compounding, 16(4): 304-309, 2012.  (ISSN:1092-4221)

73. Rattan Lal, Rakesh Kumar Marwaha, Deepti Pandita and Harish Dureja, Formulation and optimization of 5-fluorouracil loaded chitosan nanoparticles employing central composite design, Drug Delivery Letters, 2(4): 281-289, 2012. (ISSN:2210-3031)

74. Rohilla Seema, Chauhan Chanchal, Singh Ravi, Rohilla Ankur, Kaushik Dinesh, Sardana Satish, Dureja Harish, Liposomes: Preparations and Applications, International Journal of Drug Development and Research, 4(4): 108-115, 2012. (IF= 0.03) (ISSN:0975-9344)

2013

75. Garg N., Dureja Harish, Kaushik D., Co-processed Excipients: A patent review, Recent Patent Drug Delivery Formulation, 7(1): 73-83, 2013. (ISSN:1872-2113)

76. Vikas Sharma, Harish Dureja and Vipin Kumar, Computation of models for prediction of blood brain barrier permeability using molecular descriptors, Journal of Computational Methods in Sciences and Engineering, 13: 379–392, 2013. (ISSN:1472-7978)

77. Vandana Prajapati, Swagat Tripathy and Harish Dureja, Product Lifecycle Management Through Patents And Regulatory Strategies- Journal of Medical Marketing, 13: 171-180, 2013. (ISSN:1745-7904)

78. Kumar Dinesh and Dureja Harish. Pharmaceutical Excipients: Global Regulatory Issues, Indonesia Journal of Pharmacy, 24(4): 215-222, 2013. (ISSN:2338-9486)

79. Deepak Kaushik, Shivaji Rai, Harish Dureja, Vineet Mittal, Anurag Khatkar, Regulatory perspectives on medical device approval in global jurisdictions, Journal of Generic Medicine, 10: 159-171, 2013. (ISSN:1741-1343)

2014

80. Neelam Dalal, Swagat Tripathy  and Harish Dureja, Big Pharma’s Recent Challenges, Applied Clinical Research, Clinical Trials and Regulatory Affairs, 1: 28-36, 2014. (ISSN:2213-476X)

81. Tripathy S, Murthy P. N., Patra B.P., Dureja H, Badjatya J.K. A pragmatic way to sustain in generic pharma environment: PLCM through regulatory strategies, International Journal of Drug Regulatory Affairs,2(2): 31 –48, 2014. (ISSN:2321 – 7162)

82. Deepak Kaushik and Harish Dureja, Recent Innovations and Platform Technologies For Pharmaceutical Taste Masking,  Recent Patents on Drug Delivery & Formulation, 8:  37-45, 2014. (ISSN:1872-2113)

83. Anusha, Parijat Pandey and Harish Dureja, Self - Medication in relation to health locus of control, International Journal of Drug Regulatory Affairs, 2(3): 62-66, 2014. (ISSN:2321 – 7162)

84. Monika Singh, Harish Dureja and A.K. Madan,Detour matrix based adjacent path eccentric distance sum indices for (Q)SAR/QSPR Part II: Application in development of models for COX-2 inhibitory activity of indomethacin derivatives, International Journal of Computational Biology and Drug Design, 7(4): 319-340, 2014. (ISSN:1756-0756)

85. Parijat Pandy and Harish Dureja, Nanoparticles-in-microparticles systems (NiMS): an overview, Journal of Innovative Biology, 1(4):  195-199, 2014. (ISSN:2348-6473)

86. Preeti Garg, Parijat Pandey, Praveen Rewri, Rakesh Kumar Marwaha, Harish Dureja,  Box-Behnken Designed Nanoparticles-In-Microparticles System (Nims) For Formulating Mouth Dissolving Tablets of Acetazolamide, Journal of Pharmaceutical Research, 13(3): 74-76, 2014. (ISSN:0973-7200)

87. Manisha, Swagat Tripathy and Harish Dureja, Panaoramic view on Qualtiy by Design, Journal of Pharm. Tech. Res. and Mgt., 2(2): 217-231, 2014. (ISSN:2321-2217)

88. Arun Kumar Chopra, Rakesh Kumar Marwaha, Deepak Kaushik and Harish Dureja, Box-Behnken Designed Fluconzole Loaded Chitosan Nanoparticles For Ocular Delivery, Journal of Pharmaceutics and  Drug Delivery Research, 3:1, 2014. (ISSN:2325-9604)

89. Minakshi Gupta, Goswami K, Rakesh Kumar Marwaha, Harish Dureja, Safety and Antitumor Activity of Gefitinib:  An Overview, International Journal of Pharmaceutical Sci.  and Research, 5(11): 4129-4140, 2014.(ISSN:2320-5148)

90. Manisha, Swagat Tripathy and Harish Dureja, US FDA’s implementation of QbD and GDUFA- a wake up call for other regulatory agencies around the globe,  Journal of Medical Marketing: : Device, Diagnostic and Pharmaceutical Marketing,14: 108-114, 2014.(ISSN:1745-7904)

91. Neeta and Harish Dureja, Role of  Boswellic Acids In Cancer Treatment, Journal of Medical Sciences, 14: 261-269, 2014. (ISSN:1682-4474)

2015

92. Singh Balwan, Dureja Harish, Dissolution Enhancement Through Factorially Designed Porous Solid Dispersions, Drug Development and Delivery, 15(2): 60-66, 2015. (ISSN:1537-2898)

93. Jyoti and Harish Dureja, Cosmetic regulations around the globe,SKINmed Dermatology for the clinician, 13(3): 191-194, 2015. (ISSN:1751-7125)

94. Mohit Kumar, Parijat Pandey, and Harish Dureja, Box-Behnken Designed Gastro-Retentive Floating Tablets Of Famotidine,  Drug Development & Delivery, 15(3): 62-68, 2015. (ISSN:1537-2898)

95. Mundlia Jyoti, Marwaha Rakesh Kumar and Dureja Harish , Box-Behnken Designed Dual- Drug Resinate Complex For Taste Masking Of Levocetirizine Dihydrochloride and Montelukast Sodium, Pharmaceutical Technology, 39(6):  28-48. 2015. ((ISSN:1543-2521)

96. Deepak Kaushik and Harish Dureja, Ion exchange resin complexation technique for pharmaceutical taste masking: an overview, World Journal of Pharmaceutical Research, 4(6): 600-614, 2015. ((ISSN:2277-7105)

97. Deepak Kaushik and Harish Dureja, Taste masking of bitter pharmaceuticals by spray drying technique,  Journal of Chemical and Pharmaceutical Research, 7(4), 950-956, 2015. (ISSN:0975-7384)

98. Prerna Kaushik, Swagat Tripathy, Rishi Sharma and Harish Dureja, Prospective of pricing in pharmaceutical environment, Applied Clinical Research, Clinical Trials and Regulatory Affairs, 1(3), 151-156, 2015. (ISSN:2213-476X)

99. Deepak Kaushik and Harish Dureja, Central composite designed taste masked ion exchange resonates for development of azithromycin dispersible tablets, Journal of Pharmaceutical Research, 14(1), 7-14, 2015. (ISSN:0973-7200)

100. Seema Rohilla and Harish Dureja, Recent Patents, Formulation and characterization of Nanoliposomes, Recent Patents on Drug Delivery & Formulation, 9(3): 213-224, 2015. (ISSN:1872-2113)

101. Sunil Khatak and Harish Dureja, Recent Advances in Nanotechnology Based Tubercular Chemotherapy, International Journal of Pharmaceutical Sciences and Nanotechnology, 8(4), 2979-2994, 2015. (ISSN:0974-3278)

102. Sunil Khatak and Harish Dureja, Recent Techniques and Patents on Solid Lipid Nanoparticles as Novel Carrier for Drug Delivery, Recent Patents on Nanotechnology , 9(3): 150-177, 2015 (1.75) (ISSN:1872-2105)

103. Saurabh Satija, Preeti Bansal, Harish Dureja, Munish Garg, Microwave assisted extraction of bioactive compound berberine from Tinospora cordifolia and optimization using central composite design, Journal of Biological Sciences, 1-10, 2015. (ISSN:1727-3048)

104. Prerna Kaushik, Swagat Tripathy, Harish Dureja and Rishi Sharma, Anti-Monopoly and Competition Laws - Impact On The Indian Pharmaceutical Industry, Applied Clinical Research, Clinical Trials and Regulatory Affairs, 2(3), 153-157, 2015. (ISSN:2213-476X)

105. Dimple, Swagat Tripathy and Harish Dureja, Drug and Cosmetic Amendment Bill in India – A Promising Hope For Healthy Medical Device Regulatory Environment, Applied Clinical Research, Clinical Trials and Regulatory Affairs, 2(3), 133-136, 2015. (ISSN:2213-476X)

106. Minakshi Gupta, Jyoti Dahiya, Rakesh Kumar Marwaha, Harish Dureja, Therapies in Cancer Treatment: An overview, International Journal of Pharmacy and Pharmaceutical Sciences, 7(4), 1-9, 2015. (ISSN:0975-1491)

107. Nidhi Garg, Parijat Pandey, Deepak Kaushik, Harish Dureja, Development of Novel Multifunction Directly Compressible Co-Processed Excipient by Melt Granulation Technique, Journal of Pharmaceutical Investigation,  5(4), 266-274, 2015. ((ISSN:2230-973X)

108. Parveen Kumar, Swagat Tripathy and Harish Dureja, Opportunities And Challenges in Emerging Pharmaceutical Markets,  Applied Clinical Research, Clinical Trials and Regulatory Affairs, 2(3), 115-122, 2015.(ISSN:2213-476X)

109.  Dhull k, Swagat Tripathy and Harish Dureja, Cosmetics: Regulatory Scenario in USA, EU and India,. Journal of Pharmaceutical Technology, Research and  Management, 3(2), 127–139, 2015. (ISSN:2321-2217)

110. Kripi Vohra, Harish Dureja and Vandana Garg, An insight of pulses:From food to cancer treatment, Journal of Pharmacognosy and Natural products, 1(1), 108, 2015 (ISSN:2472-0992)

2016

111. Mehta M, Dureja H, Garg M, Development and optimization of boswellic acid-loaded proniosomal gel. Drug Delivery, 8:1-10, 2016. (IF= 6.4) (ISSN:1071-7544)

112. Kripi Vohra, Vivek Kumar Gupta, Harish Dureja and Vandana Garg,  Antihyperlipidemic Activity of Lens culinaris Medikus Seeds in Triton WR- 1339 Induced Hyperlipidemic Rats, Journal of Pharmacognosy & Natural Products, 2(2), 117, 2016. (ISSN:2472-0992)

113. Parijat Pandey, Rakesh Kumar Marwaha, Arun Nanda and Harish Dureja, Spray-Dried Nanoparticles-in-Microparticles System (NiMS) of Acetazolamide Using Central Composite Design, Nanoscience & Nanotechnology-Asia, 6(2): 146-156, 2016 (ISSN:2210-6812)

114. Mandeep Dahiya and Harish Dureja, Central composite designed imatinib-loaded magnetic nanoparticles, Current Nanomedicine, 6(2): 146-155, 2016 (ISSN:2468-1873)

115. Deepak Kaushik and Harish Dureja, Preparation of eudragit® loaded spray-dried microspheres for development of Roxithromycin dispersible tablets using central composite design, Applied Clinical Research, Clinical Trials and Regulatory Affairs,3(2): 127-137, 2016 ((ISSN:2213-476X)

116. Chanchal Garg, Sonia Verma, Saurabh Satija, Meenu Mehta, Harish Dureja, Munish Garg, Microwave assisted extraction of bioactive compound phyllanthin from Phyllanthus amarus and optimization using central composite design, International Journal of Pharmaceutical Science and Research, 1 (7) 30-35, 2016. (ISSN:2455-4685)

2017

117. Parijat Pandey, and Harish Dureja, Optimizing The Spray Drying Parameters For Formulation Of Nanoparticles-In-Microparticles System (NIMS) of Acetazolamide, Drug Development and Delivery, 17(1): 26-31, 2017.(ISSN:1537-2898)

118. Meenu Bhan, Saurabh Satija, Harish Dureja and Munish Garg, Optimization of ionic liquid-based microwave assisted extraction of a diterpenoid lactone-andrographolide from Andrographis paniculata by response surface methodology, Journal of Molecular Liquids, 229: 161-166, 2017.(IF=4.513)(ISSN:0167-7322)

119. Jaidev, Swagat Tripathy, Mandeep Dahiya and Harish Dureja. Emerging Nutraceutical Regulations in India. Applied Clinical Research, Clinical Trials & Regulatory Affairs, 4: 1-8, 2017.(ISSN:2213-476X)

120. Parijat Pandey and Harish Dureja, ERLOTINIB: A Targeted  Anticancer Drug,  Current cancer Therapy Reviews, 13 (1): 3-16, 2017.(ISSN:1573-3947)

121. Beena Kumari, Parijat Pandey and Harish Dureja. Formulation and characterization of gastroretentive floating tablets of atorvastatin calcium using central composite design. Journal of Pharmaceutical Research, 16(3): 247-256, 2017. (ISSN:0973-7200)

122. Manisha Saini, Swagat Tripathy, B P Patra, Harish Dureja, Rakesh Godhany, P N Murthy. ABC of Clinical trials with the mark of safety, efficacy and transparency. Applied Clinical Research, Clinical Trials and Regulatory Affairs, 4(2): 120-127, 2017. (ISSN:2213-476X)

123. Harish Dureja, Viney Lather and Dharmender Rathee. Pharmacophore modeling and 3D QSAR studies for prediction of matrix metalloproteinases inhibitory activity of hydroxamate derivatives. Biotechnology Research and Innovation, 1: 112-122, 2017 (ISSN:2452-0721)

124. Meenu Bhan, Saurabh Satija, Chanchal Garg, Harish Dureja and Munish Garg. A Novel Approach towards Green Extraction for Glycyrrhitinic acid by Ionic liquid based Microwave assisted extraction and Optimization through Response Surface Methodology. Pharmacognosy Journal, 9(6): 866-872, 2017.(ISSN:0975-3575)

125. Kripi Vohra, Harish Dureja, and Vandana Garg,  Microspheres: A Reliable Drug Delivery System For Anticancer Herbal Drugs, World Journal of Pharmaceutical Research 6 (17), 455-467 (ISSN:2277–7105)

126. Sunil Khatak and Harish Dureja. Structural Composition of Solid Lipid Nanoparticles for Invasive and Non–invasive Drug Delivery. Current Nanomaterials, 2(3): 129-153, 2017. (ISSN:2211-7385)

127. Meenakshi Gupta, Rakesh Kumar Marwaha and Harish Dureja. Development and Characterization of Gefitinib Loaded Polymeric Nanoparticles by Ionic Gelation Method. Pharmaceutical Nanotechnology, 5(4): 301-309, 2017.(ISSN: 2211-7385)

2018

128. Dharmender Rathee, Viney Lather, Ajmer Singh Grewal and Harish Dureja, Targeting matrix metalloproteinases with novel diazepine substituted cinnamic acid derivatives: design, synthesis, in vitro and in silico studies, Chemistry Central Journal, 12: 41-56, 2018. (IF= 2.284)(ISSN:1752-153X)

129. Nidhi Saiwal, Mandeep Dahiya and Harish Dureja. Recent Patents and Formulation of Nanopharmaceuticals using Ultrasonication Technique. Recent Patents on Nanotechnolgy 12(2): 86-100, 2018. (IF= 1.75) (ISSN:1872-2105)

130. Parijat Pandey and Harish Dureja, Recent Patents On Polymeric Nanoparticles For Cancer Therapy, Recent patent on Nanotechnology, 12(2): 155 – 169, 2018. (IF= 1.75) (ISSN:1872-2105)

131. Dharmender Rathee Viney Lather and Harish Dureja,. Prediction of MMP-9 inhibitory activity of N-hydroxy-α-phenylsulfonylacetamide derivatives by pharmacophore based modelling and 3-D QSAR studies. Porto Biomedical Journal, 3(1), e6, 2018. (ISSN:2244-8664)

132. Neeta and Harish Dureja. Chromatographic Methods Used For Characterization of Boswellic Acids, MOJ Drug Design Development & Therapy, 2(4): 195-201, 2018. (ISSN:2575-9094)

133. Neeta and Harish Dureja. Reverse Phase High Performance Liquid Chromatographic Estimation, Characterization and In vitro Cytotoxicity of Boswellic Acids on Melanoma Cancer Cell lines, Asian Journal of Pharmaceutical Analysis, 8(1), 13-19, 2018. (ISSN:2231-5667)

134. Mandeep Dahiya and Harish Dureja. Recent Developments in the Formulation of Nanoliposomal Delivery Systems. Current Nanomaterials, 3(2): 62-74,  2018. (ISSN:2405-4615)

135. Neeta and Harish Dureja, Impact of Surfactants on Formulation Parameters and  In vitro cytotoxicity of Boswellic Acids Loaded Nanoparticles on Human Colon Cancer Cell Lines, Indian Journal of Pharmaceutical Education and Research,52(4s2): S229-S236, 2018. (IF= 0.351) (ISSN:0019-5465)

136. Sunil Khatak, Mamta Khatak, Faraat Ali, Ashu Rathi, Robin Singh, G.N. Singh and Harish Dureja. Development and Validation of RP-HPLC Method for Simultaneous Estimation of Antitubercular Drugs in Solid Lipid Nanoparticles, Indian Journal of Pharmaceutical Sciences, 80(6): 966-1002, 2018. (IF= 0.762) (ISSN:0250-474X)

137. Parijat Pandey, Deepika Purohit and Harish Dureja. Nanosponges – A Promising Novel Drug Delivery System, Recent Patents on Nanotechnology, 12(3): 180-191,  2018 (IF= 1.75) (ISSN:1872-2105)

138. Reena, Mandeep Dahiya and Harish Dureja. Formulation and Evaluation of Microspheres Based Oro-Dispersible Roxithromycin Tablets Using Central Composite Design, International Journal of Pharmaceutical Sciences and Research, 9(11): 4651-4658, 2018. (ISSN:0975-8232)

139. Sharma Neeta, Mehta Meenu, Dureja Harish, Chandra Amrish, Pharmacoeconomics of antidiabetic drugs, Asian Journal of Pharmaceutics 12(4), S1324-S1328, 2018. (ISSN:0973-8398)

140. Parijat Pandey and Harish Dureja. Erlotinib in non-small cell lung cancer: From a thought to necessity, Clinical Cancer Drugs, 5(2): 87-93, 2018. (ISSN:2212-697x)

141. Sunil Khatak, Uttam Semwal, Manoj Kumar Pandey and Harish Dureja. Antitubercular Drugs Loaded Solid Lipid Nanoparticles as a Potential Antimycobacterial Activity against M.smegmatis, The Pharma Innovation Journal,  7(9): 325-329, 2018. (ISSN:2349-8242)

142. Parijat Pandey, Ramkishan A   and Harish Dureja. Optimizing the Formulation Variables for Erlotinib Loaded Chitosan Nanoparticles, International Journal of Pharmaceutical sciences and Research, 9(12): 5234-5239, 2018. (ISSN:0975-8232)

143. Seema Rohilla and Harish Dureja. Effect of Chitosan coating on the Physiochemical Characteristics of Gefitinib Loaded Nanoliposomes, International of Pharmaceutical Sciences and Research,  9(12): 5098-5110, 2018. (ISSN:0975-8232)

144. Mandeep Dahiya and Harish Dureja. Recent Developments in the Formulation of Nanoliposomal Delivery Systems. Current Nanomaterials,3(2): 62-74, 2018. (ISSN:2405-4615)

145. Sharma Neeta, Mehta Meenu, Dureja Harish, Chandra Amrish, Antihypertensive drugs: Are they cost-effective? Asian Journal of Pharmaceutics 12(4), S1329-S1334, 2018.(ISSN:0973-8398)

2019

146. Reena Sheoran, Sukhbir Lal Khokra, Vinay Chawla and Harish Dureja Recent Patents, Formulation Techniques, Classification and Characterization of Liposomes, Recent Patents on Nanotechnology, 13(1), 2019. (IF= 1.75)(ISSN:1872-2105)

147. Reena Siwach, Parijat Pandey, Viney Chawla and Harish Dureja, Role of Nanotechnology in Diabetic Management, Recent Patents on Nanotechnology, 13(1), 28-37, 2019. (IF= 1.75) (ISSN:1872-2105)

148. Sandeep Kumar Dhiman, Vikram Gummadi and Harish Dureja, Partnership Efforts – Their Potential to Reduce the Challenges that Confront Regulators and Pharmaceutical Industry, Applied Clinical Research, Clinical Trials & Regulatory Affairs 6(1), 7-17, 2019. (ISSN:2213-476X)

149. Dhamender Rathee, Viney Lather, Ajmer Singh Grewal and Harish Dureja. Enzymatic inhibitory activity of iridod glycosides from Picrorrhiza Kurroa against matrix metalloproteinases: Correlating in vitro targeted screening and docking, Computational Biology and chemistry, 78: 28-36, 2019 (IF= 1.581) (ISSN:1476-9271)

150. Kripi Vohra, Vandana Garg and Harish Dureja. Ethnopharmacology, Phytochemistry and Pharmacology of Lens culinaris Medikus Seeds: An Update. Current Nutrition & Food Science, 15(2) :131-139, 2019. (ISSN:1573-4013)

151. Meenu Mehta, Deeksha, Neha Sharma, Manish Vyas, Navneet Khurana, Pawan Kumar Maurya, Harjeet Singh, Terezinha Pinto Andreoli de Jesus, Harish Dureja, Dinesh Kumar Chellappan, Gaurav Gupta, Ridhima Wadhwa, Trudi Collet, Philip M. Hansbro, Kamal Dua and Saurabh Satija, Interactions with the macrophages: An emerging targeted approach using novel drug delivery systems in respiratory diseases, Chemico-Biological Interactions, 304, 10-19, 2019. (IF= 3.296)(ISSN:0009-2797)

152. Wadhwa Ridhima, Aggarwal Taru, Malyla Vamshikrishna, Kumar Nitesh, Gupta Gaurav, Chellappan Dinesh Kumar, Dureja Harish, Mehta Meenu,Satija Saurabh, Gulati Monica, Maurya Pawan Kumar, Collet Trudi, Hansbro Philip Michael and  Dua Kamal  Identification of biomarkers and genetic approaches towards chronic obstructive disease. Journal of Cellular Physiology,234(10), 16703-16723, 2019. (IF= 3.923)(ISSN:1097-4652)

153. Laura Soon, Phui Qi Ng, Jestin Chellian, Thiagarajan Madheswaran, Jithendra Panneerselvam, Gaurav Gupta, Srinivas Nammi, Nicole Hansbro, Alan Hsu, Harish Dureja, Meenu Mehta, Saurabh Satija, Philip Michael Hansbro, Kamal Dua, Trudi Collet, Dinesh Kumar Chellappan, Therapeutic potential of Artemisia vulgaris: An insight into underlying immunological mechanisms. Journal of Environmental Pathology, Toxicology and Oncology,38(3):205-216, 2019 (IF= 1.15) ((ISSN:0731-8898)

154. Kripi Vohra, Harish Dureja, Vandana Garg and Rohit Dutt, Current Trends in Phyto-cancer Therapy Using Nanoparticles, Current Nanomedicine, 9(1). 30-45, 2019 (ISSN:2468-1873)

155. Minakshi Gupta, R. K. Marwaha, Harish Dureja, Formulation and Characterization of Gefitinib-loaded Polymeric Nanoparticles Using Box-Behnken Design, Current Nanomedicine, 9(1). 46-60, 2019. (ISSN:2468-1873)

156. Saharan Anjali, Dhiman Anju and Dureja Harish, Phytochemical Analysis of Terminalia catappa LinnFruit in Ethanolic Extract Using GC-MS, International Journal of Pharmacy and Pharmaceutical Research, 16(1), 336-349, 2019 (ISSN:2349-7203)

157. Pandey Parijat, Dua Kamal and Dureja Harish, Erlotinib loaded chitosan nanoparticles: Formulation, physicochemical characterization and cytotoxic potential, International Journal of Biological Macromolecules, 139, 1304-1316, 2019. (IF= 4.784) (ISSN:0141-8130)

158. Pandey Parijat, Chellappan D. K., Tambuwala M. M., Bakshi H. A., Dua Kamal and Dureja Harish, Central composite designed formulation, characterization and in vitro cytotoxic effect of erlotinib loaded chitosan nanoparticulate system, International Journal of Biological Macromolecules, 141, 596-610, 2019. (IF= 4.784) (ISSN:0141-8130)

159. Deepika Purohit, Manisha Saini, Parijat Pandey, Swagat Tripathy, Harish Dureja. Implementation of Quality by Design: A Review, Applied Clinical Research, Clinical Trials and Regulatory Affairs,  6(2), 99-111, 2019. (ISSN:2213-476X)

160. Seema Rohilla and Harish Dureja, Vinay Chawla. Cytoprotective Agents to avoid Chemotherapy Induced Side effects on Normal Cells: A Review, Current cancer drug targets, 19 (10), 765-781, 2019. (IF= 2.72)(ISSN:1568-0096)

161. Nidhi Saiwal, Mandeep Dahiya and Harish Dureja. Nutraceutical insight into vegetables and their potential for nutrition mediated healthcare. Current Nutrition & Food Science, 15(5), 441-453, 2019.(ISSN:1573-4013)

162. Kripi Vohra, Vandana Garg and Harish Dureja Microscopic Studies On Lens Culinaris Medikus Seeds Using Bright-Field Microscope And Polarized Light Microscope. Plant Archives, 19, Supplement 2, 1980-1986, 2019. (ISSN:0972-5210)

163. Wadhwa R, Pandey P, Gupta G, Aggarwal T, Kumar N, Mehta M, Satija S, Gulati M, Madan J, Dureja H, Balusamy SR, Perumalsamy H, K Maurya P, Collet T, Tambuwala MM, Hansbro PM, Chellappan DK, Dua K. Emerging Complexity and the Need for Advanced Drug Delivery in Targeting Candida Species. Curr Top Med Chem.,19 (28): 2593-2609, 2019. (IF = 3.442) (ISSN:1568-0266)

164. Reena Siwach, Parijat Pandey, and Harish Dureja, Formulation and Characterization of Glimepiride Nanoparticles for Dissolution Enhancement, Nanoscience & Nanotechnology-Asia, 9(1), 2019. (ISSN: 2210-6812)

2020

165. Hamid A. Bakshi, Alaa A. A. Aljabali, Faruk L. Hakkim, Khalid M. Al-Batanyeh, Mazhar S. Al Zoubi, Bahaa AlTrad, Mohamed M Nasef, Saurabh Satija, Meenu Mehta, Kavita Pabreja, Vijay Mishra, Mohammed Khan, Salem Abobaker, Ibrahim M. Azzouz, Harish Dureja, Ritesh M Pabari, Ashref Ali K Dardouri, Prashant Kesharwani, Gaurav Gupta, Shakti Dhar Shukla, Prateek Prasher, Nitin B. Charbe, Poonam Negi, Deepak N Kapoor, Dinesh Kumar Chellappan, Yusuf Haggag, MateusWebba da Silva, Paul Thompson, Kamal Dua, Paul McCarron and Murtaza M. Tambuwala, Albumin Nano-Encapsulation of Piceatannol Enhances Its Anticancer Potential in Colon CancerVia Downregulation of Nuclear p65 and HIF-1α. Cancers, 12, 113, 2020 (IF= 6.639) (ISSN:2072-6694) (DOI: 0.3390/cancers12010113) 

166. Yinghan Chan, Sin Wi Ng, Joycelin Zhu Xin Tan, Gaurav Gupta , Murtaza M. Tambuwala, Hamid A. Bakshi, Harish Dureja, Kamal Dua, Muhammad Ishaq, Vanni Caruso, Dinesh Kumar Chellappan, Emerging therapeutic potential of the iridoid molecule, asperuloside: A snapshot of its underlying molecular mechanisms. Chemico-Biological Interactions, 315, 2020, 108911 (IF= 5.192) (ISSN:0009-2797)(DOI: 10.1016/j.cbi.2019.108911) 

167. Janice Kou, Tan Yu Xin, Paul McCarron, Gaurav Gupta, Harish Dureja Saurabh Satija, Meenu Mehta, Hamid A. Bakshi, Murtaza M. Tambuwala, Trudi Collet, Kamal Dua, & Dinesh Kumar Chellappanh, Going Beyond Antibiotics: Natural Plant Extracts as an Emergent Strategy to Combat Biofilm-Associated Infections. Journal of Environmental Pathology, Toxicology and Oncology, 39(2): 125 – 136, 2020. (IF= 3.567) (ISSN:0731-8898) (DOI: 10.1615/JEnvironPatholToxicolOncol.2020032665) 

168. Gupta G, Dahiya R, Singh Y, Mishra A, Verma A, Gothwal SK, Aljabali AAA, Dureja H, Prasher P, Negi P, Kapoor DN, Goyal R, Tambuwala MM, Chellappan DK, Dua K, Monotherapy of RAAS blockers and mobilization of aldosterone: A mechanistic perspective study in kidney disease. Chemico Biol Interactions, 317, 108975, 2020. (IF= 5.192) (ISSN:0009-2797) (DOI:10.1016/j.cbi.2020.108975) 

169. Meenu Mehta; Daljeet Singh Dhanjal; Bhupender Singh; Sachin Kumar Singh; Gaurav Gupta; S Rajeshkumar; Lakshmi Thangavelu; Murtaza M. Tambuwala; Hamid A. Bakshi; Dinesh Kumar Chellappan; Parijat Pandey; Harish Dureja; Nitin B. Charbe; Srinivas Nammi; Kamal Dua; Saurabh Satija, Kamal Dua,Cellular Signalling Pathways Mediating the Pathogenesis of Chronic Respiratory Diseases: An Update, Inflammopharmacology, 28, 795-817 2020. (IF= 4.473) (ISSN:0925-4692) (DOI: 10.1007/s10787-020-00698-3)

170. Gaurav Gupta, Sarita Rawat, Sachchidanand Pathak, Santosh Kumar Singh, Himmat Singh, Anurag Mishra, Ritu Gilhotra, Alaa A. A. Aljabali, Harish Dureja, Murtaza M Tambuwala, Dinesh K. Chellappan, Kamal Dua,Current Biological And Pharmacological Updates On Wogonin, Excli Journal: Experimental and Clinical Sciences, 2020, 19: 635-640. (IF= 4.068) (ISSN:1611-2156)(DOI: 10.17179/EXCLI 2020-1967) 

171. Parijat Pandey, Saurabh Satija, Ridhima Wadhwa, Meenu Mehta, Deepika Purohit, Gaurav Gupta, Parteek Prasher, Dinesh Kumar Chellapan, Rajendra Awasthi, Harish Dureja, Kamal Dua, Emerging Trends in Nanomedicine for Topical Delivery in Skin Disorders: Current and Translational Approaches. Dermatologic Therapy, 2020, e13292. (IF= 2.851) (ISSN:1529-8019)(DOI:10.1111/dth.13292) 

172. Charul Rathore, Michael J Rathbone, Dinesh K Chellappan, Murtaza M Tambuwala,Terezinha De Jesus A Pinto, Harish Dureja, Chetna Hemrajani, Gaurav Gupta, Kamal Dua & Poonam Negi, Nanocarriers: More than tour de force for thymoquinone. Expert Opinion on Drug Delivery, 2020; 17(4): 479-494. (IF= 6.648) (ISSN:1742-5247) (DOI: 10.1080/17425247.2020.1730808) 

173. Chellappan Dinesh; Woon Yee Lim; Yu Xuan Kong; Kunalan Kishen; Ching Rou Lim; Szu Jean Leong; Ying Ying Lee; Xin Wie Lee; Chellian Jestin; Mehta Meenu; Satija Saurabh; Kumar Singh Sachin; Gulati Monica; Dureja Harish; Tambuwala Murtaza; Gupta Gaurav; Paudel Keshav; Wadhwa Ridhima; M. Hansbro Philip; Dua Kamal, Targeting neutrophils using novel drug delivery systems in chronic respiratory diseases. Drug Development Research, 2020, 81(4) 419-436. (IF= 4.360) (ISSN:1098-2299)(DOI: 10.1002/ddr.21648) 

174. Mohammad Altamish, Rajiv Dahiya, Avinash Kumar Singh, Anurag Mishra, Alaa A. A. Aljabali, Saurabh Satija, Meenu Mehta, Harish Dureja, Parteek Prasher, Poonam Negi, Deepak N. Kapoor, Rohit Goyal, Murtaza M Tambuwala, Dinesh K. Chellappan, Kamal Dua and Gaurav Gupta, Role of Serine/Threonine Kinase 11 (STK11) or liver kinase B1 (LKB1) Gene in Peutz-Jeghers Syndrome. Critical Reviews™ in Eukaryotic Gene Expression, 2020, 30(3), 245-252 (IF= 2.156) (ISSN:2162-6502) (DOI: 10.1615/critreveukaryotgeneexpr.2020033451) 

175. Parteek Prasher, Mousmee Sharma, Meenu Mehta, Keshav R. Paudel, Saurabh Satija, Dinesh K. Chellappan, Harish Dureja, Gaurav Gupta, Murtaza M. Tambuwala, Poonam Negi, Peter R. Wich, Nicole G. Hansbro, Philip M. Hansbro, Kamal Dua, Plants derived therapeutic strategies targeting chronic respiratory diseases:Chemical and immunological perspective. Chemico-Biological Interactions, 325, 109125, 2020. (IF= 5.192) ((ISSN:0009-2797) (DOI: 10.1016/j.cbi.2020.109125) 

176. Reena Sheoran, Sukhbir Lal Khokra, and Harish Dureja, Preparation, optimisation and characterisation of letrozole nano-liposomes, International Journal of Pharmaceutical sciences and Research, 11(3): 1373-1379, 2020. (ISSN:2320-5148) (DOI: 10.13040/ijpsr.0975-8232.11(3).1373-79) 

177. Harminder Singh, Viney Chawla, Ritu Bala and Harish Dureja. Current and Future of Alzheimer's Therapy with the best Approach CNS & Neurological Disorders - Drug Targets, 2020, 19, 9, 691-697 (IF= 2.761) (ISSN:1871-5273) (DOI: 0.2174/1871527319666200430000538) 

178. Li Hian Chin, Chian Ming Hon, Dinesh Kumar Chellappan, Jestin Chellian, Thiagarajan Madheswaran, Farrukh Zeeshan, Rajendra Awasthi, Alaa AA. Aljabali, Murtaza M. Tambuwala, Harish Dureja, Poonam Negi, Deepak N. Kapoor, Rohit Goyal, Keshav Raj Paudel, Saurabh Satija, Gaurav Gupta, Alan Hsu, Peter Wark, Kamal Dua, Molecular mechanisms of action of naringenin in chronic airway diseases, European Journal of Pharmacology, 879, 173139, 2020. (IF= 4.432) (ISSN:0014-2999) (DOI: 10.1016/j.ejphar.2020.173139) 

179.  Sandeep Dhiman and Harish Dureja, Significance of and Challenges in Regulating Endocrine Disruptors – How Regulators and Industry can Conquer? Endocrine, Metabolic & Immune Disorders-Drug Targets, 2020, 20: 1664-1681 (IF= 2.895) (ISSN:1871-5303) (DOI:10.2174/1871530320666200606225104) 

180. Parijat Pandey, Nisha Gulati, Manish Makhija, Deepika Purohit and Harish Dureja, Nanoemulsion: A Novel Drug Delivery Approach for Enhancement of Bioavailability, Recent Patents on Nanotechnology 14, (4), 276-293 (IF= 1.952) (ISSN:1872-2105)(DOI: 10.2174/1872210514666200604145755) 

181. Saurabh Satija, Murtaza M. Tambuwala, Kavita Pabreja, Hamid A. Bakshi, Dinesh Kumar Chellappan, Alaa A. Aljabali, Srinivas Nammi, Thakur Gurjeet Singh, Harish Dureja, Gaurav Gupta, Kamal Dua, Meenu Mehta, Munish Garg, Development of Novel HPTLC Fingerprint Method for Simultaneous Estimation of Berberine and Rutin in Medicinal Plants and their Pharmaceutical Preparations followed by its Application in Antioxidant Assay, Journal of Planar Chromatography - Modern TLC, 2020, 33, 313-319 (IF= 0.856) (ISSN:0933-4173) (DOI: 10.1007/s00764-020-00035-y) 

182. Sumit Sanduria, Swagat Tripathy, P. N. Murthy, B. P. Patra, Harish Dureja, Voicing Regulatory Perspectives of the Combination Products, Journal of Generic Medicines, 16(3), 101-111 (ISSN:1741-1343)(DOI: 10.1177/1741134320936724) 

183. Hamid A. Bakshi , Mazhar S Al Zoubi, Hakkim L. Faruck, Alaa A A Aljabali, Firas A. Rabi, Amin A. Hafiz, Khalid M Al-Batanyeh, Bahaa Al-Trad, Prawej Ansari, Mohamed M. Nasef, Nitin B. Charbe, Saurabh Satija, Meenu Mehta, Vijay Mishra, Gaurav Gupta, Salem Abobaker, Poonam Negi, Ibrahim M. Azzouz, Ashref Ali K Dardouri, Harish Dureja, Parteek Prasher, Dinesh K. Chellappan , Kamal Dua, Mateus Webba Da Silva, Mohamed El Tanani, Paul A. McCarron and Murtaza M. Tambuwala Dietary Crocin is Protective in Pancreatic Cancer while Reducing Radiation-Induced Hepatic Oxidative Damage, Nutrients, 12(6) 1901. (IF= 5.719) (ISSN: 2072-6643) (DOI:10.3390/nu12061901) 

184. Mousmee Sharma, Parteek Prasher, Meenu Mehta, Flavia C. Zacconi, Yogendra Singh, Deepak N. Kapoor, Harish Dureja, Dinesh M. Pardhi, Murtaza M. Tambuwala, Gaurav Gupta, Dinesh K. Chellappan, Kamal Dua, Saurabh Satija, Probing 3CL protease: Rationally designed chemical moieties for COVID ‐19, Drug Development Research, 2020; 81, 911-918. (IF= 4.360) (Online ISSN:1098-2299)(DOI: 10.1002/ddr.21724) 

185. Gurmandeep Kaur, Sachin Kumar Singh, Rajesh Kumar, Bimlesh Kumar, Yogita Kumari, Monica Gulati, Narendra Kumar Pandeya, K. Gowthamarajan, Dipanjoy Ghosh, A. Clarisse, Sheetu Wadhwa, Meenu Mehta, Saurabh Satija, Kamal Dua, Harish Dureja, Saurabh Gupta, Pankaj Kumar Singh, Bhupinder Kapoor, Nitin Chitranshi, Ankit Kumar, Omji Porwal, Development of modified apple polysaccharide capped silver nanoparticles loaded with mesalamine for effective treatment of ulcerative colitis, Journal of Drug Delivery Science and Technology, 60, 101980, 2020. (IF = 3.981) (ISSN: 1773-2247) (DOI: 10.1016/j.jddst.2020.101980) 

186. Swagat Tripathy, Pooja Mehra, P. N. Murthy, B. P. Patra, Harish Dureja, Challenges and prospects in Chinese pharmaceutical Regulatory Environment, Journal of Generic Medicines 2020, 16(3), 101-111 (ISSN:1741-1343). (DOI:10.1177/1741134320954256) 

187. Alaa A.A. Aljabali, Hamid A. Bakshi, Saurabh Satija, Meenu Metha, Parteek Prasher, Raed M. Ennab, Dinesh Kumar Chellappan, Gaurav Gupta, Poonam Negi, Rohit Goyal, Ashish Sharma, Vijay Mishra, Harish Dureja, Kamal Dua and Murtaza M. Tambuwala, COVID-19: Underpinning research for detection, therapeutics, and vaccines development, Pharmaceutical Nanotechnology, 2020, 8(4), 323-353. (ISSN: 2211-7385; (DOI:10.2174/2211738508999200817163335)

188. Neeta Solanki, Meenu Mehta, Dinesh Kumar Chellappan, Gaurav Gupta, Nicole G Hansbro, Murtaza M Tambuwala, Alaa AA Aljabali, Keshav Raj Paudel , Gang Liu, Saurabh Satija, Philip M Hansbro, Kamal Dua, Harish Dureja, Antiproliferative Effects of Boswellic Acids Loaded Chitosan Nanoparticles on Human Lung Cancer Cell Line A549, Future Medicinal Chemistry, 2020, 12(22):2019-2034 (IF= 3.808) (ISSN (print): 1756-8919 | ISSN (online): 1756-8927)(DOI: 10.4155/fmc-2020-0083) 

189. Meenu Mehta, Parteek Prasher, Mousmee Sharma, Madhur D. Shastri, Navneet Khurana, Manish Vyas, Harish Dureja, Gaurav Gupta, Krishnan Anand, Saurabh Satija, Dinesh Kumar Chellappan, Kamal Dua, Advanced drug delivery systems can assist in targeting coronavirus disease (COVID-19): A hypothesis; Medical Hypotheses 144 (2020) 110254 (IF= 1.375) (ISSN: 0306-9877) (DOI: 10.1016/j.mehy.2020.110254). 

190. Narendra Kumar Pandey, Sachin Kumar Singh, Monica Gulati, Bimlesh Kumar, Bhupinder Kapoor,Dipanjoy Ghosh, RajanKumar, Rubia Khursheed, Ankit Awasthi, Gowthamarajan Kuppusamy, Sheetu Wadhwa, Saurabh Satija, Harish Dureja, Subheet KumarJain, Dinesh Kumar Chellappan, Krishnan Anand, Meenu Mehta, Kamal Dua, Overcoming the dissolution rate, gastrointestinal permeability and oral bioavailability of glimepiride and simvastatin co-delivered in the form of nanosuspension and solid self-nanoemulsifying drug delivery system: A comparative study, Journal of Drug Delivery Science and Technology, 2020, 60, 102083 (IF = 2.734) (ISSN: 1773-2247) (DOI: 10.1016/j.jddst.2020.102083). 

191. Sunil Khatak, Meenu Mehta, Rajendra Awasthi, Keshav Raj Paudel, Sachin Kumar Singh, Monica Gulati, Nicole G. Hansbro, Philip M. Hansbro, Kamal Dua, Harish Dureja, Solid lipid nanoparticles containing anti-tubercular drugs attenuate the Mycobacterium marinum infection, Tuberculosis, 125, 2020, 102008 (IF= 2.576) (ISSN: 1472-9792) (DOI: 10.1016/j.tube.2020.102008) 

192. Mehta, Meenu, Keshav R. Paudel, Shakti D. Shukla, Madhur Shastri, Sachin K. Singh, Monica Gulati, Harish Dureja, Gaurav Gupta, Saurabh Satija, Philip M. Hansbro, Dinesh K. Chellappan, and Kamal Dua. Interferon therapy for preventing COPD exacerbations. EXCLI J. 2020, 190: 1477-80. (IF= 4.068) (eISSN 1611-2156) (doi: 10.17179/excli2020-2997). 

193. Ridhima Wadhwa, Keshav Raj Paudel, Li Hian Chin Chian Ming Hon Thiagarajan Madheswaran, Gaurav Gupta, Jithendra Panneerselvam Thangavelu Lakshmi, Sachin Kumar Singh, Monica Gulati, Harish Dureja, Alan Hsu, Meenu Mehta, Krishnan Anand, Hari Prasad Devkota, Jestin Chellian, Dinesh Kumar Chellappan, Philip M. Hansbro, Kamal Dua, Anti-inflammatory and anti-cancer activities of Naringenin-loaded liquid crystalline nanoparticles in vitro, Journal of Food Biochemistry, 2020, 29;e13572. (IF=2.720) (Online ISSN:1745-4514)(DOI: 10.1111/jfbc.13572). 

2021 

194. Harpreet Kaur Khanuja, Rajendra Awasthi, Meenu Mehta, Saurabh Satija, Alaa AA Aljabali, Murtaza M. Tambuwala, Dinesh Kumar Chellappan, Kamal Dua, Harish Dureja, Nanosuspensions – An Update on Recent Patents, Methods of Preparation, and Evaluation Parameters, Recent Patents on Nanotechnology, 2021. 15(4) 351-366 ISSN 1872-2105) (DOI: 10.2174/1872210514666201224103010).

195. Arya Kadukkattil Ramanunny, Sheetu Wadhwa, Monica Gulatia, Sachin Kumar Singh, Bhupinder Kapoor, Harish Dureja, Dinesh Kumar Chellappan, Krishnan Anand, Kamal Dua, Rubiya Khursheed, Ankit Awasthi, Rajan Kumar, Jaskiran Kaur, Leander Corrie, Narendra KumarPandey, Nanocarriers for treatment of dermatological diseases: Principle, perspective and practices, European Journal of Pharmacology, 2021, 890, 173691 (IF= 4.4.32) (ISSN: 0014-2999) (doi: 10.1016/j.ejphar.2020.173691).

196. Rubiya Khursheed, Sachin Kumar Singh, Sheetu Wadhwa, Monica Gulati, Bhupinder Kapoor, Ankit Awasthi, Arya Kr, Rajan Kumar, Faheem Hyder Pottoo, Vijay Kumar, Harish Dureja, Krishnan Anand, Dinesh Kumar Chellappan, Kamal Dua and K. Gowthamarajan, Opening eyes to therapeutic perspectives of bioactive polyphenols and their nanoformulations against diabetic neuropathy and related complications. Expert Opinion in drug delivery, 2021, 18(4), 427-448. (IF= 6.648) (ISSN:1742-5247) (DOI: 10.1080/17425247.2021.1846517) 

197. Saurabh Satija, Harpreet Kaur, Murtaza M. Tambuwala, Prabal Sharma, Manish Vyas, Navneet Khurana, Neha Sharma, Hamid A. Bakshi, Nitin B. Charbe, Flavia C Zacconi, Alaa A. Aljabali, Srinivas Nammi, Harish Dureja, Thakur Gurjeet Singh, Gaurav Gupta, Daljeet S. Dhanjal, Kamal Dua, Dinesh Kumar Chellappan, Meenu Mehta, Hypoxia-inducible factor (HIF): fuel for cancer progression, Current Molecular Pharmacology, 2021, 14(3), 321-332 (IF= 3.283) (DOI : 10.2174/1874467214666210120154929) 

198. Krishnan Anand, Naeem Sheik Abdul, Terisha Ghazi, Muthusamy Ramesh, Gaurav Gupta, Murtaza M. Tambuwala, Harish Dureja, Sachin Kumar Singh, Dinesh Kumar Chellappan, Kamal Dua, Boomi Pandi, Muthupandian Saravanan, and Anil Amichund Chuturgoon, Induction of Caspase-Mediated Apoptosis in HepG2 Liver Carcinoma Cells Using Mutagen–Antioxidant Conjugated Self-Assembled Novel Carbazole Nanoparticles and In Silico Modeling Studies, ACS Omega. 2021, 6, 1, 265–277 (IF= 2.87) (https://doi.org/10.1021/acsomega.0c04461). 

199. Niraj Kumar Jha, Shreesh Ojha, Saurabh Kumar Jha, Harish Dureja, Sachin Kumar Singh, Shakti D. Shukla, Dinesh Kumar Chellappan, Gaurav Gupta, Shanu Bhardwaj, Neeraj Kumar, Madhan Jeyaraman, Rashmi Jain, Sathish Muthu, Rohan Kar, Dhruv Kumar, Vineet Kumar Goswami, Janne Ruokolainen, Kavindra Kumar Kesari, Sandeep Kumar Singh, Kamal Dua, Evidences of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations, Journal of Molecular Neuroscience, 2021, 71, 2192–2209 (IF= 2.678) (DOI: https://doi.org/10.1007/s12031-020-01767-6). 

     1. Li-Yen Lee, Geena Suet Yin Hew, Meenu Mehta, Shakti D. Shukla, Saurabh Satija, Navneet Khurana, Krishnan Anand, Harish Dureja, Sachin Kumar Singhd, Vijay Mishra, Pankaj Kumar Singh, Monica Gulati, Parteek Prasher, Alaa A. A. Aljabali, Murtaza M. Tambuwala, Lakshmi Thangavelu, Jithendra Panneerselvam, Gaurav Gupta, Flavia C. Zacconi, Madhur Shastri, Niraj Kumar Jha, Dikaia Xenaki, Ronan MacLoughlin, Brian G. Oliver, Dinesh Kumar Chellappan Kamal Dua, Targeting eosinophils in respiratory diseases: Biological axis, emerging therapeutics and treatment modalities, Life Sciences, 2021, 267, 118973 (IF= 5.037) (DOI: https://doi.org/10.1016/j.lfs.2020.118973 ) 

200. Gaurav Gupta, Imran Kazmi, Fahad A. Al-Abbasi, Yogendra Singh , Suneha Rani , Anurag Mishra, Parteek Prasher , Niraj Kumar Jha, Lakshmi Thangavelu, Harish Dureja, Sachin K Singh, Shvetank Bhatt , Dinesh Kumar Chellappan, Kamal Dua, Activation of TWEAK/Fnl4 signaling suppresses TRAFs/NF-kB pathway in the pathogenesis of cancer, EXCLI Journal. 2021, 20, 232-235.(IF= 4.068) (DOI: https://doi.org/10.17179/excli2021-3378). 

201. Seyed H Shahcheraghi, Jamshid Ayatollahi, Alaa A A Aljabali , Madhur D Shastri, Shakti D Shukla, Dinesh K Chellappan, Niraj Jha, Krishnan Anand, Naresh K Katari, Meenu Mehta, Saurabh Satija, Harish Dureja, Vijay Mishra, Abdulmajeed G Almutary, Abdullah M Alnuqaydan, Nitin Charbe, Parteek Prasher, Gaurav Gupta, Kamal Dua, Marzieh Lotfi, Hamid Bakshi, Murtaza M Tambuwala, An overview of vaccine development for COVID-19, Therapeutic Delivery, 2021, 12(3), 235-244 (ISSN: 2041-5990) (DOI: 10.4155/tde-2020-0129) 

202. Kripi Vohra, Meenu Mehta, Vandana Garg, Kamal Dua, Harish Dureja, Formulation, characterisation and In vitro cytotoxic effect of Lens culinaris Medikus seeds extract loaded chitosan microspheres, Current Molecular Pharmacology, 2021, 14(3), 448-457 (IF= 3.283) (ISSN: 1874-4672) DOI : 10.2174/1874467214666210210124739. 

203. Yogendra Singh, Haider Ali, Khalid Saad Alharbi, Waleed Hassan Almalki, Imran Kazmi Fahad, A. Al‐Abbasi, Krishnan Anand, Harish Dureja, Sachin K. Singh, Lakshmi Thangavelu, Dinesh Kumar Chellappan, Kamal Dua, Gaurav Gupta, Calcium sensing receptor hyperactivation through viral envelop protein E of SARS CoV2: A novel target for cardio‐renal damage in COVID‐19 infection, Drug Development Research, 2021, 82(6), 784-788., (IF= 4.360) (Online ISSN:1098-2299) (DOI: https://doi.org/10.1002/ddr.21810). 

204. Pooja Rathee, Swagat Tripathy, Sahil Khatter, BP Patra, PN Murthy, Harish Dureja, 505(b) (2) - A smart pathway to differentiate from competitive, low margin environment of generics, Journal of Generic Medicine, 2021, 2021, 17(4), 183-194 (DOI: https://doi.org/10.1177/1741134320987866). 

205. Sandeep Dhiman and Harish Dureja, Comparative analysis of evolution of regulatory environment in USA, Europe and Japan, Pharma Innovation 2021;10(2):06-14. (DOI: 10.22271/tpi.2021.v10.i2a.5657). 

206. Meenu Mehta, Keshav Raj Paudel, Shakti D Shukla, Madhur D Shastri, Saurabh Satija, Sachin Kumar Singh, Monica Gulati, Harish Dureja, Flavia C Zacconi, Philip M Hansbro, Dinesh Kumar Chellappan, Kamal Dua, Rutin-loaded liquid crystalline nanoparticles attenuate oxidative stress in bronchial epithelial cells: a PCR validation, Future Medicinal Chemistry, 13, 6, 543-549 (IF= 3.808) (DOI: https://doi.org/10.4155/fmc-2020-0297). 

207. Nisha Gulati, Dinesh Kumar Chellappan, Murtaza M. Tambuwala, Alaa A. A. Aljabali, Parteek Prasher, Sachin Kumar Singh, Krishnan Anand, Ankur Sharma, Niraj Kumar Jha, Gaurav Gupta, Kamal Dua, and Harish Dureja, Oral nanoemulsion of Fenofibrate: formulation, characterization and in vitro drug release studies, ASSAY and Drug Development Technologies, 19(4), 2021, 246-261 (IF= 1.738) (ISSN: 1540-658X) (Doi:https://doi.org/10.1089/adt.2021.012) 

208. Jaskiran Kaur, Vijay Mishra, Sachin Kumar Singh, Monica Gulati, Bhupinder Kapoor, Dinesh Kumar Chellappan, Gaurav Gupta, Harish Dureja, Krishnan Anand, Kamal Dua, Gopal L. Khatik, Kuppusamy Gowthamarajan, Harnessing amphiphilic polymeric micelles for diagnostic and therapeutic applications: Breakthroughs and bottlenecks, Journal of Controlled Release, 2021, 334, 64-95 (IF= 7.727). (DOI: https://doi.org/10.1016/j.jconrel.2021.04.014) 

209. Parteek Prasher, Mousmee Sharma, Meenu Mehta, Saurabh Satija, Alaa A. Aljabali, Murtaza M. Tambuwala, Krishnan Anand, Nitin Sharma, Harish Dureja, Niraj Kumar Jha, Gaurav Gupta, Monica Gulati, Sachin Kumar Singh, Dinesh K. Chellappan, Keshav R. Paudel, Philip M. Hansbro, Kamal Dua, Current-status and applications of polysaccharides in drug delivery systems, Colloid and Interface Science Communications, 2021, 42, 100418 (IF= 4.914) (DOI: https://doi.org/10.1016/j.colcom.2021.100418). 

210. Nisha Gulati, Kamal Dua, Harish Dureja, Role of chitosan based nanomedicines in the treatment of chronic respiratory diseases, International Journal of Biological Macromolecules, 2021, 185, 20-30 (IF= 6.953) (DOI:https://doi.org/10.1016/j.ijbiomac.2021.06.035) 

211. Abdullah M Alnuqaydan, Abdulmajeed G Almutary, Arulmalar Sukamaran, Brian Tay Wei Yang, Xiao Ting Lee, Wei Xuan Lim, Yee Min Ng, Rania Ibrahim, Thiviya Darmarajan, Satheeshkumar Nanjappan, Jestin Chellian, Mayuren Candasamy, Thiagarajan Madheswaran, Ankur Sharma, Harish Dureja, Parteek Prasher, Nitin Verma, Deepak Kumar, Kishneth Palaniveloo, Dheeraj Bisht, Gaurav Gupta, Jyotsana R. Madan, Sachin Kumar Singh, Niraj Kumar Jha, Kamal Dua, and Dinesh Kumar Chellappan, Middle East Respiratory Syndrome (MERS) Virus—Pathophysiological Axis and the Current Treatment Strategies, AAPS PharmSciTech (2021) 22(5): 173 (IF= 3.246) DOI: https://doi.org/10.1208/s12249-021-02062-2 

212. Alaa AA Aljabali, Sk Sarif Hassan, Ritesh M Pabari, Seyed H Shahcheraghi, Vijay Mishra, Nitin B Charbe, Dinesh K Chellappan, Harish Dureja, Gaurav Gupta, Abdulmajeed G Almutary, Abdullah M Alnuqaydan, Suresh K Verma, Pritam K Panda, Yogendra Kumar Mishra, Ángel Serrano-Aroca, Kamal Dua, Vladimir N Uversky, Elrashdy M Redwan, Bojlul Bahar, Amit Bhatia, Poonam Negi, Rohit Goyal, Paul McCarron, Hamid A Bakshi & Murtaza M Tambuwala, The viral capsid as novel nanomaterials for drug delivery, Future Science OA, 2021, FSO744, (DOI: https://doi.org/10.2144/fsoa-2021-0031) 

213. Sandeep Dhiman and Harish Dureja, SAHPRA - Relevance of the New South African Health Products Regulatory Authority and Opportunities Ahead, Journal of Regulatory Science, 2021, 9(2), 1-14, (Doi: https://doi.org/10.21423/jrs-v09i2dureja) 

214. Swagat Tripathy, PN Murthy, BP Patra, Sumit Sanduria, Harish Dureja, Repositioning current combination product with intellectual property and regulatory strategies, Research J. Pharm. and Tech. 2021; 14(12): , 

215. Swagat Tripathy, PN Murthy, BP Patra, Sumit Sanduria and Harish Dureja, Endocrine Disruptors (EDs) regulatory waves: A frictional lens perspective on regulated and emerging markets, International Journal of Pharmaceutical Sciences and Drug Research, 2021;13(2):230-239, (DOI: https://doi.org/10.25004/IJPSDR.2021.130218). 

216. Madhan Jeyaraman, Sathish Muthu, Asawari Bapat, Rashmi Jain, Sushmitha ES, Arun Gulati, Talagavadi Channaiah Anudeep, Shirodkar Jaswandi Dilip, Niraj Kumar Jha, Dhruv Kumar, Kavindra Kumar Kesari, Shreesh Ojha, Sunny Dholpuria, Gaurav Gupta, Harish Dureja, Dinesh Kumar Chellappan, Sachin Kumar Singh, Kamal Dua, Saurabh Kumar Jha, Bracing NK cell based therapy to relegate pulmonary inflammation in COVID-19, Heliyon, 2021 Jul;7(7):e07635. (IF= 2.85) DOI: 10.1016/j.heliyon.2021.e07635 

217. Garima Shrivastava, Alaa AA Aljabali, Seyed Hossein Shahcheraghi, Marzieh Lotfi, Madhur D Shastri, Shakti D Shukla, Dinesh K Chellappan, Niraj Kumar Jha, Krishnan Anand, Harish Dureja, Ritesh M Pabari, Vijay Mishra, Abdulmajeed G Almutary, Abdullah M Alnuqaydan, Nitin Charbe, Parteek Prasher, Poonam Negi, Rohit Goyal, Kamal Dua, Gaurav Gupta, Angel Serrano-Aroca, Bojlul Bahar, Debmalya Barh, Pritam Kumar Panda, Kazuo Takayama, Kenneth Lundstorm, Paul McCarron, Hamid Bakshi & Murtaza M Tambuwala, Targeting LIN28: a new hope in prostate cancer theranostics, Future Oncology, 2021, 17, 29, 3873-3880 (IF = 3.404) (Doi: www.futuremedicine.com/doi/10.2217/fon-2021-0247. 

218. Swagat Tripathy, PN Murthy, BP Patra, Sumit Sanduria and Harish Dureja, Endocrine Disruptors (EDs) regulatory waves: A frictional lens perspective on regulated and emerging markets, International Journal of Pharmaceutical Sciences and Drug Research, 2021;13(2):230-239, (DOI: https://doi.org/10.25004/IJPSDR.2021.130218) 

219. Ankur Sharma , Susan Hawthorne, Saurabh Kumar Jha, Niraj Kumar Jha, Dhruv Kumar, Samuel Girgis, Vineet Kumar Goswami, Gaurav Gupta, Sachin Singh, Harish Dureja, Dinesh Kumar Chellappan, Kamal Dua, Effects of curcumin-loaded poly(lactic-co-glycolic acid) nanoparticles in MDA-MB231 human breast cancer cells, Nanomedicne, 16, 20, 1763-73 (IF= 5.307) (DOI: https://doi.org/10.2217/nnm-2021-0066). 

220. Ankur Sharma, Dhruv Kumar, Kajal Dahiya, Susan Hawthorne, Saurabh Kumar Jha, Niraj Kumar Jha, Parma Nand, Samuel Girgis, Sibi Raj, Rashi Srivastava, Vineet Kumar Goswami, Yiota Gregoriou, Sally A El-Zahaby, Shreesh Ojha, Harish Dureja, Gaurav Gupta, Sachin Singh, Dinesh Kumar Chellappan & Kamal Dua, Advances in pulmonary drug delivery targeting microbial biofilms in respiratory diseases, Nanomedicine, 16 (21), 1905-1923 (IF= 5.307) (DOI: https://doi.org/10.2217/nnm-2021-0057). 

221. Nisha Gulati, Dinesh Kumar Chellappan, Ronan MacLoughlin, Kamal Dua, Harish Dureja, Inhaled nano-based therapeutics for inflammatory lung diseases: Recent advances and future prospects, Life Sciences, 285(3), 2021, 119969 (IF= 5.037) (https://doi.org/10.1016/j.lfs.2021.119969). 

222. Neeraj Kumar, Harish Dureja, Amrish Chandra, Enhancement Of Drug Dissolution Of Erlotinib Tablets By Micronization Technique Using Pharmaceutical Experimental Design, Journal of Pharmaceutical Research International, 2021, 33 (51A) 70-78 DOI: 10.9734/jpri/2021/v33i51A33470 

223. Arya Kadukkattil Ramanunny, Sachin Kumar Singh, Sheetu Wadhwa, Monica Gulati, Bhupinder Kapoor, Rubiya Khursheed, Gowthamarajan Kuppusamy, Kamal Dua, Harish Dureja, Dinesh Kumar Chellappan, Niraj Kumar Jha, Piyush Kumar Gupta & Sukriti Vishwas, Overcoming hydrolytic degradation challenges in topical delivery: non-aqueous nano-emulsions, Expert Opinion on Drug Delivery, 2021, 19(1), 23-45 (IF= 6.648) (DOI:https://doi.org/10.1080/17425247.2022.2019218). 

224. Prapti Pattanayak, Sachin Kumar Singh, Monica Gulati, Sukriti Vishwas, Bhupinder Kapoor, Dinesh Kumar Chellappan, Krishnan Anand, Gaurav Gupta, Niraj Kumar Jha, Piyush Kumar Gupta, Parteek Prasher, Kamal Dua, Harish Dureja, Deepak Kumar & Vijay Kumar, Microfluidic chips: recent advances, critical strategies in design, applications and future perspectives, Microfluidics and Nanofluidics, 25, 1-28 (2021) (IF = 2.529). https://doi.org/10.1007/s10404-021-02502-2. 

225. Gaurav Gupta, Roshan S., Yogendra Singh, Lakshmi Thangavelu, Sachin Kumar Singh, Harish Dureja, Dinesh Kumar Chellappan, Kamal Dua, Emerging cases of mucormycosis under COVID-19 pandemic in India: Misuse of antibiotics, Drug Development Research,82(7), 880–882. IF= 4.360 DOI: https://doi.org/10.1002/ddr.21862. 

226. 
     

     2. 1. 2022 

227. Muhammad Bello Usman, Shreesh Ojha, Saurabh Kumar Jha, Dinesh Kumar Chellappan, Gaurav Gupta, Sachin Kumar Singh, Kamal Dua, Shubhadeep Roychoudhury, Neeraj Kumar, Firdos Alam Khan, Harish Dureja, Vijay Upadhye, Flavia Zacconi, Pragya Prasanna, Kavindra Kumar Kesari, Ghulam Md Ashraf, Athanasios Alexiou, Niraj Kumar Jha, Biological databases and tools for Neurological disorders, Journal of Integrative Neuroscience, 2022, 21(1), 41, ISSN: 0219-6352, (IF: 1.664) DOI: https://doi.org/10.31083/j.jin2101041. 

228. Dinesh Kumar Chellappan, Parteek Prasher, Vilashini Saravanan, Vanessa See Vern Yee, Wendy Chai Wen Chi, Jia Wei Wong, Joon Kang Wong, Jing Tong Wong, Wai Wan, Jestin Chellian, Nagashekhara Molugulu, Sakthivel Lakshmana Prabu, Rania Ibrahim, Thiviya Darmarajan, Mayuren Candasamy, Pankaj Kumar Singh, Vijay Mishra, Madhur D. Shastri, Flavia C. Zacconi, Amlan Chakraborty, Meenu Mehta, Piyush Kumar Gupta, Harish Dureja, Monica Gulati, Sachin Kumar Singh, Gaurav Gupta, Niraj Kumar Jha, Brian Gregory George Oliver, Kamal Dua, Protein and peptide delivery to lungs by using advanced targeted drug delivery, Chemico-Biological Interactions, Volume 351, 2022, 109706. IF=5.168 , DOI: https://doi.org/10.1016/j.cbi.2021.109706

229. Mandeep Dahiya and Harish Dureja, Sorafenib for Hepatocellular Carcinoma: Potential Molecular Targets and Resistance Mechanisms, Journal of Chemotherapy, 2022, 19(7), 771-793 (IF 2.385)DOI: https://doi.org/10.1080/1120009X.2021.1955202 

230. Bhupinder Kapoor, Apoorva Singh, Monica Gulati, Sachin Kumar Singh, Pooja Rani, Qushmua Alzahrani, Kamal Dua, Harish Dureja, Leander Corrie, Orchestration of Obesolytic Activity of Microbiome: Metabiotics at Centre Stage, Current Drug Metabolism, 2022, 23(2), 90-98 (IF= 3.408) ISSN: 1389-2002, DOI: 10.2174/1389200223666220211095024 

231. Seema Rohilla, Rajendra Awasthi, Meenu Mehta, Dinesh Kumar Chellappan, Gaurav Gupta, Monica Gulati, Sachin Kumar Singh, Krishnan Anand, Brian G. Oliver, Kamal Dua, Harish Dureja, Preparation and Evaluation of Gefitinib Containing Nanoliposomal Formulation for Lung Cancer Therapy, BioNanoScience , 2022, 12, 241–255 (ISSN: 21911630, 21911649) DOI: 10.1007/s12668-022-00938-6 

232. Shanu Bhardwaj, Kavindra Kumar Kesari, Mahesh Rachamalla, Shalini Mani, Ghulam Md Ashraf, Saurabh Kumar Jha, Pravir Kumar, Rashmi K Ambasta, Harish Dureja, Hari Prasad Devkota, Gaurav Gupta, Dinesh Kumar Chellappan, Sachin Kumar Singh, Kamal Dua, Janne Ruokolainen, Mohammad Amjad Kamal, Shreesh Ojha, Niraj Kumar Jha,, CRISPR-Cas9 gene editing: New hope for Alzheimer's disease therapeutics, Journal of Advanced Research, 2022, 40, 207-221. (IF= 10.479), (DOI: https://doi.org/10.1016/j.jare.2021.07.001) 

233. Narendra Kumar Pandey, Sachin Kumar Singh, Bimlesh Kumar, Monica Gulati, Sukriti Vishwas, Rubiya Khursheed, Harish Dureja, Dinesh Kumar Chellappan, Niraj Kumar Jha, Ankur Sharma, Saurabh Kumar Jha, Piyush Kumar Gupta, Saurabh Gupta, Gaurav Gupta, Parteek Prasher & Kamal Dua, Expanding arsenal against diabetes mellitus through nanoformulations loaded with glimepiride and simvastatin: A comparative study, Environmental Science and Pollution Research, 2022, 29(34), 51976–51988. (IF= 5.190) DOI: https://doi.org/10.1007/s11356-022-19371-z 

234. Shakti D. Shukla, Madhur D. Shastri, Swaroop K. Vanka, Niraj Kumar Jha, Harish Dureja, Gaurav Gupta, Dinesh Kumar Chelappan, Brian G. Oliver, Kamal Dua, E. Haydn Walters,Targeting intercellular adhesion molecule-1 (ICAM-1) to reduce rhinovirus-induced acute exacerbations in chronic respiratory diseases, Inflammopharmacology 2022, 30(3), 725–735. (IF= 5.093), https://doi.org/10.1007/s10787-022-00968-2 

235. Ritika Puri, Vimal Arora, Atul Kabra, Harish Dureja and Shailendra Hamaal, Magnetosomes: A Tool for Targeted Drug Delivery in the Management of Cancer, Journal of Nanomaterials 2022, Article 6414585, 12 pages, (IF= 3.791) DOI: https://doi.org/10.1155/2022/6414585 

236. Swagat Tripathy, PN Murthy, BP Patra, Vikram, Sumit Sanduria, Harish Dureja, Strategic archetype of Herbal Medicine Product (HMP) in Regulated and Emerging Market, Research Journal of Pharmacy and Technology, 2022, 15(5) 1973 (DOI: 10.52711/0974-360X.2022.00328) 

237. Jaskiran Kaur, Monica Gulati, Flavia Zacconi, Harish Dureja, Raimar Loebenberg, Md Salahuddin Ansari, Othman AlOmeir, Aftab Alam, Dinesh Kumar Chellappan, Gaurav Gupta, Niraj Kumar Jha, Terezinha de Jesus Andreoli Pinto, Andrew Morris, Yahya E. Choonara, Jon Adams, Kamal Dua & Sachin Kumar Singh, Biomedical Applications of polymeric micelles in the treatment of diabetes mellitus: Current success and future approaches, Expert Opinion on Drug Delivery, 2022, 19 (7), 771-793 (IF= 8.129) (DOI: https://doi.org/10.1080/17425247.2022.2087629). 

238. Anjali Saharan, Harish Dureja, Anju Dhiman, Pharmacognostic, Phytochemical and Optimization Studies of Hydroalcoholic Extract of Terminalia catappa Linn. Dried Fruit, Research Journal Of Chemistry and Environment, 2022, 26(7):111-119 (Doi: https://doi.org/10.25303/2607rjce1110119) 

239. Dinesh K. Chellappan,Parteek Prasher,Shakti D. Shukla,Tong W. Yee,Tiong K. Kah,Toh W. Xyan,Tang W. Kid,Teoh H. Si,Ting S. Weng,Nagashekhara Molugulu,Lakshmana P. Sakthivel,Jestin Chellian,Thiagarajan Madheswaran,Himaja Malipeddi,Yogendra Singh,Harish Dureja,Deepak N. Kapoor,Poonam Negi,Rohit Goyal,Lakshmi Thangavelu,Deepak Kumar,Piyush K. Gupta,Niraj K. Jha,Madhur D. Shastri,Ronan MacLoughlin,Sachin K. Singh,Monica Gulati,Gaurav Gupta,Kamal Dua, Exploring the role of antibiotics and steroids in managing respiratory diseases, Journal of Molecular and Biochemical Toxicology, 2022, 36 (10),, e23174, Doi: https://doi.org/10.1002/jbt.23174 

240. Mandeep Dahiya, Rajendra Awasthi, Gaurav Gupta, Sachin Kumar Singh, Monica Gulati, Niraj Kumar Jha, Saurabh Kumar Jha, Ankur Sharma, Parteek Prasher, Krishnan Anand, Dinesh Kumar Chellappan, Kamal Dua, and Harish Dureja, Optimization Studies on Imatinib Mesylate Loaded Nanoliposomes Using Box-Behnken Design. Nano Biomed. Eng., 2022, 14(1): 23-37. (ISSN 2150-5578) DOI: 10.5101/nbe.v14i1.p23-37 

241. Nitin Verma, Vimal Arora, Rajendra Awasthi, Yinghan Chan, Niraj Kumar Jha, Komal Thapaa Talha Jawaid, Mehnaz Kamal, Gaurav Gupta, Gang Liu, Keshav Raj Paudel, Philip Michael Hansbro, Brian Gregory George Oliver, Sachin Kumar Singh, Dinesh Kumar Chellappan, Harish Dureja, Kamal Dua, Recent developments, challenges and future prospects in advanced drug delivery systems in the management of tuberculosis, Journal of Drug Delivery Science and Technology, 2022, 75, 103690. (IF= 5.062) DOI: 10.1016/j.jddst.2022.103690. 

242. Leander Corrie, Jaskiran Kaur, Ankit Awasthi , Sukriti Vishwas, Monica Gulati, Sumant Saini, Bimlesh Kumar, Narendra Kumar Pandey, Gaurav Gupta, Harish Dureja, Dinesh Kumar Chellapan, Kamal Dua, Devesh Tewari and Sachin Kumar Singh/Multivariate Data Analysis and Central Composite Design-Oriented Optimization of Solid Carriers for Formulation of Curcumin-Loaded Solid SNEDDS: Dissolution and Bioavailability Assessment/Pharmaceutics 2022, 14(11), 2395; (IF= 6.525), https://doi.org/10.3390/pharmaceutics14112395. 

243. Sumel Ashique, Kirti Gupta, Gaurav Gupta, Neeraj Mishra, Sachin Kumar Singh, Sheetu Wadhwa, Monica Gulati, Harish Dureja, Flavia Zacconi, Brian G. Oliver, Keshav Raj Paudel, Philip M. Hansbro, Dinesh Kumar Chellappan, Kamal Dua/Vitamin D—A prominent immunomodulator to prevent COVID-19 infection, Int J Rheum Dis. 2023;26:13–30. (IF= 2.558) DOI: https://doi.org/10.1111/1756-185X.14477 

244. Ankit Awasthi, Bimlesh Kumar, Monica Gulati, Sukriti Vishwas, Leander Corrie, Jaskiran Kaur, Rubiya Khursheed, Rozhan Arif Muhammed, Duran Kala, Omji Porwal, Malakapogu Ravindra Babu, M. V. N. L. Chaitanya, Ankit Kumar, Narendra Kumar Pandey, Harish Dureja, Dinesh Kumar Chellappan, Niraj Kumar Jha, Gaurav Gupta, Parteek Prasher, Deepak Kumar, Kamal Dua & Sachin Kumar Singh Novel Nanostructured Lipid Carriers Co-Loaded with Mesalamine and Curcumin: Formulation, Optimization and In Vitro Evaluation, Pharmaceutical Research, 39, 2817–2829. (IF= 4.580) (ISSN: DOI: https://doi.org/10.1007/s11095-022-03401-z. 

245. Parteek Prasher, Mousmee Sharma, Yinghan Chan, Sachin Kumar Singh, Krishnan Anand, Harish Dureja, Niraj Kumar Jha, Gaurav Gupta, Flavia Zacconi, Dinesh K. Chellappan and Kamal Dua, Recent Trends in rationally designed molecules as kinase inhibitors, Current Medicinal Chemistry, 2022 (Ahead of print). ISSN: 0929-8673 (IF=4.740) (DOI: 10.2174/0929867328666211111161811).  

246. Virender Kumar, Vandana Garg, Harish DurejaAn update review on drug repurposing for COVID-19, TMR Pharmacology Research, 2022, Vol. 2, (3): No. 12     DOI:10.53388/PR202202012

247. Virender Kumar, Vandana Garg, Harish Dureja, Ananas comosus loaded nanoemulsion a promising therapeutic approach for cancer, Cancer Advances,  2022, 5, No. e22017     DOI:10.53388/2022522017

248. Virender Kumar, Neha Minocha, Vandana Garg, Harish Dureja, Nanostructured materials used in drug delivery, Materials today: Proceedings: 69 (part 2), 174-180, DOI: https://doi.org/10.1016/j.matpr.2022.08.306.

249. Virender Kumar, Vandana Garg, Harish Dureja, Nanomedicine-based approaches for delivery of herbal compounds,, Traditional Medicine Research,  2022,  7(5) : No.48     DOI:10.53388/TMR20220223001

250. Virender Kumar, Vandana Garg, Harish Dureja, Role of traditional herbal medicine in treatment of malaria, TMR Modern Herbal Medicine,  2022, 5(4): No. 20     DOI:10.53388/MHM2022B0816001. 

     2. 1. 2023 

251. Harpreet Kaur Khanuja, Harish Dureja, Recent Patents and Potential Applications of Homogenisation Techniques in Drug Delivery Systems, Recent Patents on Nanotechnology, 2023, 17(1), 33-50, (IF= 2.321), (ISSN: 1872-2105) (DOI : 10.2174/1872210515666210719120203) 

252. Virender, Dureja Harish, Garg Vandana, Traditional use, Phytochemistry and Pharmacology of Ananas comosus: An Update in Current Nutrition and Food Sciences, 2023, 19(4), 428-441. (ISSN: 1573-4013) (Doi: 10.2174/1573401318666220509140201). 

253. Rajendra Awasthi, Anurag Kumar Singh, Gaurav Mishra, Anand Maurya, Neerupma Dhiman, Harsha Kharkwal, Bhupesh Sharma, Niraj Kumar Jha, Harish Dureja, Kamal Dua, Terezinha de Jesus Andreoli Pinto and Giriraj T. Kulkarni, Diagnosis and Clinical Aspects of Lung Cancer: A Special Emphasis on Drug Targeting to Cancer Cells through Nanoparticles, Letters in Drug Design and Discovery, 2023, 20(5), 499-516. (IF= 1.099) (ISSN: 1570-1808) (DOI: 10.2174/1570180819666220510133408) 

254. Mandeep Dahiya, Rajendra Awasthi, Kamal Dua, Harish Dureja Sorafenib tosylate loaded superparamagnetic nanoparticles: Development, optimization and cytotoxicity analysis on HepG2 human hepatocellular carcinoma cell line/Journal of Drug Delivery Science and Technology, 2023 (79), 104044. DOI: https://doi.org/10.1016/j.jddst.2022.104044 

255. Imran Kazmi, Mohammad Arshad Javed Shaikh, Obaid Afzal, Abdulmalik Saleh Alfawaz Altamimi, Waleed Hassan Almalki, Sami I. Alzarea, Fahad A. Al-Abbasi, Manisha Pandey, Harish Dureja, Sachin Kumar Singh, Kamal Dua, Gaurav Gupta, Chitosan-based nano drug delivery system for lung cancer, Journal of Drug Delivery Science and Technology, 2023 (81), 104196.

256. Dahiya, Mandeep, Rajendra Awasthi, Jaya Parkash Yadav, Shammi Sharma, Kamal Dua, and Harish Dureja, Chitosan based sorafenib tosylate loaded magnetic nanoparticles: Formulation and in-vitro characterization, International Journal of Biological Macromolecules, 2023, 242, 124919.

257. Prasher, Parteek, Mousmee Sharma, Yinghan Chan, Sachin K. Singh, Krishnan Anand, Harish Dureja, Niraj Kumar Jha et al.,  Recent trends in rationally designed molecules as kinase inhibitors." Current Medicinal Chemistry 2023, 30(13),  1529-1567.

258. Nisha Gulati, Kamal Dua and Harish Dureja, Enhancing the therapeutic potential of nanomedicines by modifying surface characteristics, Current Drug Delivery, 2023, 20(8), 1031-36, (IF=3.758) (DOI: : 10.2174/1567201819666220508175434) 

259. Minakshi Gupta Marwaha, Rajendra Awasthi, Rakesh Kumar Marwaha, Parteek Prasher, Monica Gulati, Sachin Kumar Singh, Krishnan Anand, Gaurav Gupta, Dinesh Kumar Chellappan, Kamal Dua and Harish Dureja, Emerging Applications of Polymeric Nanoparticles in Tumor Targeting, Current Nanoscience, 19 (5), 677-696 (IF= 1.5) DOI: 10.2174/1573413718666220928114233.

260. Chhabra, Jatin, Hitesh Chopra, Rakesh Pahwa, Neha Raina, Karan Wadhwa, Swati Saini, Poonam Negi et al. Potential of nanoemulsions for accelerated wound healing: innovative strategies,  International Journal of Surgery (London, England) (2023).

261. Solanki, Neeta, Gaurav Gupta, Dinesh Kumar Chellappan, Sachin Kumar Singh, Monica Gulati, Keshav Raj Paudel, Philip M. Hansbro et al. "Boswellic Acids: A Critical Appraisal of Their Therapeutic and Nutritional Benefits in Chronic Inflammatory Diseases." Endocrine, Metabolic & Immune Disorders Drug Targets (2023).

262. Kumar, Virender, Vandana Garg, and Harish Dureja. "Therapeutic Application of Pineapple: A Review." Recent Advances in Food, Nutrition & Agriculture (2023).

263. Rohilla, Seema, Ankur Rohilla, Sonia Narwal, Harish Dureja, and Deepak Prabhakar Bhagwat. "Global Trends of Cosmeceutical in Nanotechnology: A Review." Pharmaceutical Nanotechnology (2023).

264. Chhabra, Jatin, Priyanka Kashyap, Rakesh Pahwa, Rakesh Narang, Harish Dureja, Sukhbir Lal, and Sangeeta Verma. "Recent Insights into Osimertinib Analogues against EGFR Positive Nonsmall Cell Lung Cancer." Current topics in medicinal chemistry.

265. Kumar, V., D. Kumar, V. Garg, and H. Dureja. "An updated review of pineapple and its bioactive compounds in breast cancer." Cancer Adv 6 (2023): e23005.

266.